ClinicalTrials.gg
CompletedNCT01475955Updated Oct 28, 2016Results posted

Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)

A Phase 2 interventional study of Broad Area ALA 1-hour incubation and Broad Area ALA 2 hour incubation in Actinic Keratosis, sponsored by DUSA Pharmaceuticals, Inc.. Completed at 13 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-10-28.

Sponsored by DUSA Pharmaceuticals, Inc. (part of Sun Pharmaceutical Industries Limited) · Phase 2, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
235
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 29 studies testing Aminolevulinic Acid in Keratosis, Actinic — 1 open to participants now, 2 under way, none of them phase 3. Aminolevulinic Acid · Keratosis, Actinic.

Enrollment
4th of 29
235 · median 32
Started
2011
with 1 other
Phase 2
11 of 29
none open now
Registered
5th of 29
by date
Lead sponsor
9 of 29
DUSA Pharmaceuticals, Inc.

Among the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, this one is the 4th largest by enrollment, is one of 2 that started in 2011, is one of 11 in phase 2, and was the 5th registered.

Keratosis, Actinic

343 studies on the registry are indexed under Keratosis, Actinic; 29 are open to participants now.

Browse Keratosis, Actinic studies →

Open to participants now

1 of the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

About Aminolevulinic Acid

Aminolevulinic Acid: first FDA approval 1999 (LEVULAN), first EMA approval 2007. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 21 Keratosis, Actinic studies recruiting now, 16 (76%) set no upper age limit and 1 (5%) stops at 75 or younger; none take children under 18; 2 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, or all of them as a file.
02

Study summary

The purpose of this study is to determine if Levulan Photodynamic Therapy (PDT) is safe and effective in the treatment of actinic keratosis when applied to broad areas on the face and scalp for 1, 2 and 3 hours.

03

Conditions studied

  • Actinic Keratosis

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 6-20 Grade 1/2 AKs on the face or scalp
  • a history of AK therapy within the treatment area at least twice in the two years prior to study entry

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Grade 3 AKs or atypical AKs (e.g., AK > 1 cm2 in size) within the Treatment Area
  • lesions suspicious for skin cancer (skin cancer not ruled out by ) or untreated skin cancers within the Treatment Area
  • plans to be exposed to artificial tanning devices or excessive sunlight during the trial
  • Subject is
  • unsuccessful outcome from previous ALA-PDT therapy
  • history of cutaneous photosensitization, porphyria, to porphyrins or photodermatosis
  • skin pathology or condition which could interfere with the evaluation of the test product or requires the use of interfering topical or systemic therapy
  • skin pathology or condition that could interfere with the evaluation of the test product or requires the use of interfering topical or systemic therapy
  • any condition which would make it unsafe for the subject to participate in this research study
  • currently enrolled in an drug or device study
  • has received an investigational drug or been treated with an investigational device within 30 days prior to the initiation of treatment
  • known sensitivity to one or more of the vehicle components (ethyl alcohol, isopropyl alcohol, laureth 4, polyethylene glycol)
  • Subject has;

    • an active herpes simplex infection OR
    • a history of 2 or more outbreaks within the past 12 months, in the Treatment Area
  • use of the following topical preparations on the extremities to be treated:

    • Keratolytics including urea (greater than 5%), alpha hydroxyacids [e.g.glycolic acid, lactic acid, etc. greater than 5%], salicylic acid (greater than 2%) within 2 days of initiation of treatment.
    • Cryotherapy within 2 weeks of initiation of treatment
    • Retinoids, including tazarotene, adapalene, tretinoin, retinol, within 4 weeks of initiation of treatment.
    • Microdermabrasion, laser ablative treatments, ALA-PDT, chemical peels, 5-FU, diclofenac, imiquimod or other topical treatments for AK within 8 weeks of initiation of treatment.
    • Two or more ALA PDT treatments in the past 6 months
  • use of systemic retinoid therapy within 6 months of initiation of treatment.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
235 participants (actual)

Study arms

  • Experimental
    Broad Area ALA 1-hour incubation

    Broad Area ALA 1-hour incubation

    Drug: Broad Area ALA 1-hour incubation · Device: Blue Light Treatment

  • Experimental
    Broad Area ALA 2-hour incubation

    Broad Area ALA 2-hour incubation

    Drug: Broad Area ALA 2 hour incubation · Device: Blue Light Treatment

  • Experimental
    Broad Area ALA 3-hour incubation

    Broad Area ALA 3-hour incubation

    Drug: broad area ALA 3-hour incubation · Device: Blue Light Treatment

  • Experimental
    Spot ALA 2-hour incubation

    Spot ALA 2-hour incubation

    Drug: Spot ALA 2 hour incubation · Device: Blue Light Treatment

  • Placebo comparator
    Vehicle PDT

    VEH group will be randomized (1:1:1:1) to be balanced for the four active groups; broad area application for 1, 2 or 3 hours or spot application for 2 hours prior to BLUE light treatment. Subjects receiving VEH will be considered a single treatment group.

    Drug: Vehicle PDT · Device: Blue Light Treatment

Interventions

  • 20% ALA, broad area, 1 hour incubation

    Also known as: Levulan

  • 20% ALA broad area 2-hour incubation

    Also known as: Levulan

  • 20% ALA broad area 3 hour incubation

    Also known as: Levulan

  • 20% ALA spot 2 hour incubation

    Also known as: Levulan

  • DrugVehicle PDT

    Levulan Kerastick containing vehicle ingredients only.VEH group will be randomized (1:1:1:1) to be balanced for the four active groups; broad area application for 1, 2 or 3 hours or spot application for 2 hours prior to BLUE light treatment. Subjects receiving VEH will be considered a single treatment group.

  • DeviceBlue Light Treatment

    10 J/cm2 blue light delivered at 10 mW/cm2

    Also known as: BLU-U

06

What researchers measure

Primary outcomes

  1. Complete Clearance Rate

    The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

    Time frame: Week 12

Secondary outcomes

  1. Complete Clearance Rate

    The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

    Time frame: Week 4

  2. Complete Clearance Rate

    The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

    Time frame: Week 8

  3. Complete Clearance Rate

    the proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

    Time frame: Week 24

  4. Partial Clearance Rate

    proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.

    Time frame: Baseline, Week 4

  5. Partial Clearance Rate

    proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.

    Time frame: Baseline, Week 8

  6. Partial Clearance Rate

    proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.

    Time frame: Baseline, Week 12

  7. Partial Clearance Rate

    proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.

    Time frame: Baseline Week 24

  8. AK Clearance Rate

    AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]

    Time frame: Baseline, Week 4

  9. AK Clearance Rate

    AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]

    Time frame: Baseline, Week 8

  10. AK Clearance Rate

    AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]

    Time frame: Baseline, Week 12

  11. AK Clearance Rate

    AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]

    Time frame: Baseline, Week 24

  12. Subject Satisfaction Score

    0 = no improvement or worsening (not satisfied at all) 1. = slight improvement (slightly satisfied) 2. = moderate improvement (moderately satisfied) 3. = excellent improvement (very satisfied)

    Time frame: Week 24

  13. Hyperpigmentation at Baseline

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: Baseline

  14. Hyperpigmentation at Visit 2

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 24-48 Hours after PDT #1

  15. Hyperpigmentation at Visit 3

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: Week 2

  16. Hyperpigmentation at Visit 4

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: Week 4

  17. Hyperpigmentation at Visit 5

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: Week 8

  18. Hyperpigmentation at Visit 6

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: Week 12

  19. Hyperpigmentation at Visit 7

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: Week 24

  20. Hypopigmentation at Baseline

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: Baseline

  21. Hypopigmentation at Visit 2

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: 24-48 Hours after PDT #1

  22. Hypopigmentation at Visit 3

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: Week 2

  23. Hypopigmentation at Visit 4

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: Week 4

  24. Hypopigmentation at Visit 5

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: Week 8

  25. Hypopigmentation at Visit 6

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: Week 12

  26. Hypopigmentation at Visit 7

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

    Time frame: Week 24

  27. Erythema at Baseline

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: Baseline

  28. Erythema Post-Light Treatment

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 5 minutes after PDT #1

  29. Erythema at Visit 2

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 24-48 hours after PDT #1

  30. Erythema at Visit 3

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: Week 2

  31. Erythema at Visit 4

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: Week 4

  32. Erythema at Visit 5 (Pre-drug)

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: Week 8 pre-drug

  33. Erythema at Visit 5 (Post-light)

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: Week 8 5 minutes post light treatment

  34. Erythema at Visit 6

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: Week 12

  35. Erythema at Visit 7

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: Week 24

  36. Edema at Baseline

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: Baseline

  37. Edema Post-Light Treatment

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 5 minutes after PDT #1

  38. Edema at Visit 2

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 24-48 hours post PDT#1

  39. Edema at Visit 3

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: Week 2

  40. Edema at Visit 4

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: Week 4

  41. Edema at Visit 5 (Pre-drug)

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: Week 8 pre-drug

  42. Edema Post PDT #2

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 5 minutes post PDT #2

  43. Edema at Week 12

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: Week 12

  44. Edema at Week 24

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: Week 24

  45. Stinging/Burning at Baseline

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

    Time frame: Baseline

  46. Stinging/Burning During Light Treatment

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

    Time frame: During PDT #1 (most intense sensation)

  47. Stinging/Burning Post Light-Treatment

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

    Time frame: 5 minutes post PDT #1

  48. Stinging/Burning at Visit 2

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

    Time frame: 24-48 hours post PDT #1

  49. Stinging/Burning at Visit 3

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

    Time frame: Week 2

  50. Stinging/Burning at Visit 4

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

    Time frame: Week 4

  51. Stinging/Burning at Visit 5 (Pre-drug)

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

    Time frame: Week 8 prior to drug

  52. Stinging/Burning at Visit 5 During PDT#2

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

    Time frame: during PDT #2

  53. Stinging/Burning at Visit 5 Post PDT#2

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

    Time frame: 5 minutes post PDT #2

  54. Stinging/Burning at Visit 6

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

    Time frame: Week 12

  55. Stinging/Burning at Visit 7

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

    Time frame: Week 24

  56. Scaling and Dryness at Baseline

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: Baseline

  57. Scaling and Dryness at Visit 2

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 24-48 hours after PDT #1

  58. Scaling and Dryness at Visit 3

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: Week 2

  59. Scaling and Dryness at Visit 4

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: Week 4

  60. Scaling and Dryness at Visit 5

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: Week 8

  61. Scaling and Dryness at Visit 6

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: Week 12

  62. Scaling and Dryness at Visit 7

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: Week 24

  63. Oozing/Vesiculation/Crusting at Baseline

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: Baseline

  64. Oozing/Vesiculation/Crusting at Visit 2

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 24-48 hours after PDT #1

  65. Oozing/Vesiculation/Crusting at Visit 3

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: Week 2

  66. Oozing/Vesiculation/Crusting at Visit 4

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: Week 4

  67. Oozing/Vesiculation/Crusting at Visit 5

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: Week 8

  68. Oozing/Vesiculation/Crusting at Visit 6

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: Week 12

  69. Oozing/Vesiculation/Crusting at Visit 7

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: Week 24

07

Results

Posted Dec 24, 2013

Participant flow

Participant flow — Overall Study
MilestoneBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Started4848474646
Completed4748444646
Not completed10300

Outcome measures

PrimaryComplete Clearance Rate

The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

Time frame:
Week 12
Reported as:
Number · participants
Complete Clearance Rate
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Complete Clearance Rate1471381
Statistical analysis
  • Broad Area ALA 1-hour + BLUE Light Treatment vs Broad Area ALA 2-hour + BLUE Light Treatment vs Broad Area ALA 3-hour + BLUE Light Treatment vs Spot ALA 2-hour + BLUE Light Treatment vs Vehicle + BLUE Light Treatment · Chi-squared · p = 0.0041
SecondaryComplete Clearance Rate

The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

Time frame:
Week 4
Reported as:
Number · participants
Complete Clearance Rate
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Complete Clearance Rate58540
SecondaryComplete Clearance Rate

The proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

Time frame:
Week 8
Reported as:
Number · participants
Complete Clearance Rate
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Complete Clearance Rate37840
SecondaryComplete Clearance Rate

the proportion of subjects in each treatment group with a count of zero lesions in the Treatment Area

Time frame:
Week 24
Reported as:
Number · participants
Complete Clearance Rate
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Complete Clearance Rate1131221
SecondaryPartial Clearance Rate

proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.

Time frame:
Baseline, Week 4
Reported as:
Number · participants
Partial Clearance Rate
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Partial Clearance Rate121614122
SecondaryPartial Clearance Rate

proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.

Time frame:
Baseline, Week 8
Reported as:
Number · participants
Partial Clearance Rate
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Partial Clearance Rate101315131
SecondaryPartial Clearance Rate

proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.

Time frame:
Baseline, Week 12
Reported as:
Number · participants
Partial Clearance Rate
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Partial Clearance Rate232425205
SecondaryPartial Clearance Rate

proportion of subjects with 75% or more reduction in the AK count in the Treatment Area as compared to baseline.

Time frame:
Baseline Week 24
Reported as:
Number · participants
Partial Clearance Rate
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Partial Clearance Rate181924173
SecondaryAK Clearance Rate

AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]

Time frame:
Baseline, Week 4
Reported as:
Median · percent clearance
AK Clearance Rate
percent clearanceBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
AK Clearance Rate40 ± 41.858.4 ± 34.854.5 ± 30.456.3 ± 54.30.0 ± 28.7
SecondaryAK Clearance Rate

AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]

Time frame:
Baseline, Week 8
Reported as:
Median · percent clearance
AK Clearance Rate
percent clearanceBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
AK Clearance Rate35.7 ± 42.052.5 ± 37.257.1 ± 37.057.1 ± 43.85.7 ± 33.5
SecondaryAK Clearance Rate

AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]

Time frame:
Baseline, Week 12
Reported as:
Median · percent clearance
AK Clearance Rate
percent clearanceBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
AK Clearance Rate71.4 ± 34.873.6 ± 31.178.6 ± 30.568.3 ± 39.47.1 ± 44.3
SecondaryAK Clearance Rate

AK Clearance Rate (AKCR) for a subject is defined as: 100% x \[1 - (Number of AK lesions in the Treatment Area at follow-up visit/Number of AK lesions in the Treatment Area at Baseline)\]

Time frame:
Baseline, Week 24
Reported as:
Median · percent clearance
AK Clearance Rate
percent clearanceBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
AK Clearance Rate66.7 ± 43.464.9 ± 36.375.0 ± 46.363.4 ± 44.314.3 ± 44.0
SecondarySubject Satisfaction Score

0 = no improvement or worsening (not satisfied at all) 1. = slight improvement (slightly satisfied) 2. = moderate improvement (moderately satisfied) 3. = excellent improvement (very satisfied)

Time frame:
Week 24
Reported as:
Number · participants
Subject Satisfaction Score
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
3 = excellent improvement (very satisfied)202120207
2 = moderate improvement (moderately satisfied)141619179
1 = slight improvement (slightly satisfied)69126
0 = no improvement or worsening (not satisfied at724724
SecondaryHyperpigmentation at Baseline

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
Baseline
Reported as:
Number · participants
Hyperpigmentation at Baseline
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None128171411
Grade 1 - Light2324232127
Grade 2 - Moderate/small1214697
Grade 3 - Moderate/moderate02121
SecondaryHyperpigmentation at Visit 2

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
24-48 Hours after PDT #1
Reported as:
Number · participants
Hyperpigmentation at Visit 2
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None1712181516
Grade 1 - Light1924231925
Grade 2 - Moderate/small9115114
Grade 3 - Moderate/moderate21111
SecondaryHyperpigmentation at Visit 3

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
Week 2
Reported as:
Number · participants
Hyperpigmentation at Visit 3
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None1610201615
Grade 1 - Light1827212324
Grade 2 - Moderate/small1210574
Grade 3 - Moderate/moderate11102
SecondaryHyperpigmentation at Visit 4

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
Week 4
Reported as:
Number · participants
Hyperpigmentation at Visit 4
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None1611221612
Grade 1 - Light2125152125
Grade 2 - Moderate/small1011697
Grade 3 - Moderate/moderate01301
SecondaryHyperpigmentation at Visit 5

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
Week 8
Reported as:
Number · participants
Hyperpigmentation at Visit 5
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None1611171411
Grade 1 - Light1926202325
Grade 2 - Moderate/small1210786
Grade 3 - Moderate/moderate01112
SecondaryHyperpigmentation at Visit 6

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
Week 12
Reported as:
Number · participants
Hyperpigmentation at Visit 6
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None179181711
Grade 1 - Light1829162024
Grade 2 - Moderate/small118988
Grade 3 - Moderate/moderate12111
SecondaryHyperpigmentation at Visit 7

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
Week 24
Reported as:
Number · participants
Hyperpigmentation at Visit 7
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None169201813
Grade 1 - Light2327192125
Grade 2 - Moderate/small710467
Grade 3 - Moderate/moderate02111
Grade 4 - Marked10000
SecondaryHypopigmentation at Baseline

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
Baseline
Reported as:
Number · participants
Hypopigmentation at Baseline
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2120302218
Grade 1 - Light2125162324
Grade 2 - Moderate/small53114
SecondaryHypopigmentation at Visit 2

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
24-48 Hours after PDT #1
Reported as:
Number · participants
Hypopigmentation at Visit 2
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2524312323
Grade 1 - Light1620142220
Grade 2 - Moderate/small64213
SecondaryHypopigmentation at Visit 3

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
Week 2
Reported as:
Number · participants
Hypopigmentation at Visit 3
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2523312120
Grade 1 - Light1722142421
Grade 2 - Moderate/small53214
SecondaryHypopigmentation at Visit 4

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
Week 4
Reported as:
Number · participants
Hypopigmentation at Visit 4
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade - None2520291919
Grade 1 - Light1721162622
Grade 2 - Moderate/small51014
Grade 3 - Moderate/moderate00100
SecondaryHypopigmentation at Visit 5

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
Week 8
Reported as:
Number · participants
Hypopigmentation at Visit 5
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2319281718
Grade 1 - Light2126172523
Grade 2 - Moderate/small33043
SecondaryHypopigmentation at Visit 6

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
Week 12
Reported as:
Number · participants
Hypopigmentation at Visit 6
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2320261915
Grade 1 - Light2126182026
Grade 2 - Moderate/small32063
Grade 3 - Moderate/moderate00010
SecondaryHypopigmentation at Visit 7

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation Grade 4 = Marked hypopigmentation involving moderate or large sized areas

Time frame:
Week 24
Reported as:
Number · participants
Hypopigmentation at Visit 7
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2218282017
Grade 1 - Light2227152425
Grade 2 - Moderate/small33124
SecondaryErythema at Baseline

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
Baseline
Reported as:
Number · participants
Erythema at Baseline
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None1410151915
Grade 1 - Minimal2323241918
Grade 2 Mild10158811
Grade 3 - Moderate00002
SecondaryErythema Post-Light Treatment

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
5 minutes after PDT #1
Reported as:
Number · participants
Erythema Post-Light Treatment
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None20004
Grade 1 - Minimal845925
Grade 2 Mild1916131814
Grade 3 - Moderate162622183
Grade 4 - Severe22710
SecondaryErythema at Visit 2

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
24-48 hours after PDT #1
Reported as:
Number · participants
Erythema at Visit 2
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None201013
Grade 1 - Minimal8341117
Grade 2 Mild101412914
Grade 3 - Moderate252318242
Grade 4 - Severe281220
SecondaryErythema at Visit 3

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
Week 2
Reported as:
Number · participants
Erythema at Visit 3
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None115111415
Grade 1 - Minimal2223192621
Grade 2 Mild13181468
Grade 3 - Moderate12301
Grade 4 - Severe00000
SecondaryErythema at Visit 4

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
Week 4
Reported as:
Number · participants
Erythema at Visit 4
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None1213161214
Grade 1 - Minimal2722202618
Grade 2 Mild8139712
Grade 3 - Moderate00111
Grade 4 - Severe00000
SecondaryErythema at Visit 5 (Pre-drug)

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
Week 8 pre-drug
Reported as:
Number · participants
Erythema at Visit 5 (Pre-drug)
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None1315172112
Grade 1 - Minimal2517221920
Grade 2 Mild9165610
Grade 3 - Moderate00102
Grade 4 - Severe00000
SecondaryErythema at Visit 5 (Post-light)

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
Week 8 5 minutes post light treatment
Reported as:
Number · participants
Erythema at Visit 5 (Post-light)
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None10104
Grade 1 - Minimal857928
Grade 2 Mild19107197
Grade 3 - Moderate121916135
Grade 4 - Severe13000
SecondaryErythema at Visit 6

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
Week 12
Reported as:
Number · participants
Erythema at Visit 6
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None1615182217
Grade 1 - Minimal2423191918
Grade 2 Mild710748
Grade 3 - Moderate00011
Grade 4 - Severe00000
SecondaryErythema at Visit 7

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
Week 24
Reported as:
Number · participants
Erythema at Visit 7
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light Treatment at Visit 1 and ViBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2016192721
Grade 1 - Minimal1920201516
Grade 2 Mild712547
Grade 3 - Moderate10002
Grade 4 - Severe00000
SecondaryEdema at Baseline

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
Baseline
Reported as:
Number · participants
Edema at Baseline
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None00100
Grade 1 - Minimal00000
Grade 2 - Mild00000
Grade 3 - Moderate00000
Grade 4 - Severe00000
SecondaryEdema Post-Light Treatment

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
5 minutes after PDT #1
Reported as:
Number · participants
Edema Post-Light Treatment
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None3728273344
Grade 1 - Minimal81211102
Grade 2 - Mild27330
Grade 3 - Moderate01600
Grade 4 - Severe00000
SecondaryEdema at Visit 2

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
24-48 hours post PDT#1
Reported as:
Number · participants
Edema at Visit 2
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None3231262744
Grade 1 - Minimal81010132
Grade 2 - Mild53640
Grade 3 - Moderate23420
Grade 4 - Severe01100
SecondaryEdema at Visit 3

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
Week 2
Reported as:
Number · participants
Edema at Visit 3
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4644424444
Grade 1 - Minimal12121
Grade 2 - Mild02400
Grade 3 - Moderate00000
Grade 4 - Severe00000
SecondaryEdema at Visit 4

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
Week 4
Reported as:
Number · participants
Edema at Visit 4
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4647464645
Grade 1 - Minimal11000
Grade 2 - Mild00000
Grade 3 - Moderate00000
Grade 4 - Severe00000
SecondaryEdema at Visit 5 (Pre-drug)

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
Week 8 pre-drug
Reported as:
Number · participants
Edema at Visit 5 (Pre-drug)
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4748454644
Grade 1 - Minimal00000
Grade 2 - Mild00000
Grade 3 - Moderate00000
Grade 4 - Severe00000
SecondaryEdema Post PDT #2

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
5 minutes post PDT #2
Reported as:
Number · participants
Edema Post PDT #2
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None3220182643
Grade 1 - Minimal6127111
Grade 2 - Mild24340
Grade 3 - Moderate11300
Grade 4 - Severe00000
SecondaryEdema at Week 12

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
Week 12
Reported as:
Number · participants
Edema at Week 12
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4748434644
Grade 1 - Minimal00100
Grade 2 - Mild00000
Grade 3 - Moderate00000
Grade 4 - Severe00000
SecondaryEdema at Week 24

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
Week 24
Reported as:
Number · participants
Edema at Week 24
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4748434545
Grade 1 - Minimal00111
Grade 2 - Mild00000
Grade 3 - Moderate00000
Grade 4 - Severe00000
SecondaryStinging/Burning at Baseline

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

Time frame:
Baseline
Reported as:
Number · participants
Stinging/Burning at Baseline
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4748474644
Grade 1 - MInimal00002
Grade 2 - Moderate00000
Grade 3 - Severe00000
SecondaryStinging/Burning During Light Treatment

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

Time frame:
During PDT #1 (most intense sensation)
Reported as:
Number · participants
Stinging/Burning During Light Treatment
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None210335
Grade 1 - MInimal159101611
Grade 2 - Moderate232922196
Grade 3 - Severe791580
SecondaryStinging/Burning Post Light-Treatment

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

Time frame:
5 minutes post PDT #1
Reported as:
Number · participants
Stinging/Burning Post Light-Treatment
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None851840
Grade 1 - MInimal291719256
Grade 2 - Moderate82519130
Grade 3 - Severe21800
SecondaryStinging/Burning at Visit 2

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

Time frame:
24-48 hours post PDT #1
Reported as:
Number · participants
Stinging/Burning at Visit 2
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2523203541
Grade 1 - MInimal182017104
Grade 2 - Moderate44711
Grade 3 - Severe01300
SecondaryStinging/Burning at Visit 3

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

Time frame:
Week 2
Reported as:
Number · participants
Stinging/Burning at Visit 3
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4645444645
Grade 1 - MInimal13200
Grade 2 - Moderate00100
Grade 3 - Severe00000
SecondaryStinging/Burning at Visit 4

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

Time frame:
Week 4
Reported as:
Number · participants
Stinging/Burning at Visit 4
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4547464644
Grade 1 - MInimal21000
Grade 2 - Moderate00001
Grade 3 - Severe00000
SecondaryStinging/Burning at Visit 5 (Pre-drug)

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

Time frame:
Week 8 prior to drug
Reported as:
Number · participants
Stinging/Burning at Visit 5 (Pre-drug)
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4748454542
Grade 1 - MInimal00012
Grade 2 - Moderate00000
Grade 3 - Severe00000
SecondaryStinging/Burning at Visit 5 During PDT#2

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

Time frame:
during PDT #2
Reported as:
Number · participants
Stinging/Burning at Visit 5 During PDT#2
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None410428
Grade 1 - MInimal201172316
Grade 2 - Moderate152016130
Grade 3 - Severe25810
SecondaryStinging/Burning at Visit 5 Post PDT#2

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

Time frame:
5 minutes post PDT #2
Reported as:
Number · participants
Stinging/Burning at Visit 5 Post PDT#2
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None7221035
Grade 1 - MInimal261814229
Grade 2 - Moderate8151190
Grade 3 - Severe02400
SecondaryStinging/Burning at Visit 6

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

Time frame:
Week 12
Reported as:
Number · participants
Stinging/Burning at Visit 6
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4748444443
Grade 1 - MInimal00021
Grade 2 - Moderate00000
Grade 3 - Severe00000
SecondaryStinging/Burning at Visit 7

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable The most intense stinging/burning sensation during the 16 minute 40 second light treatment will be recorded.

Time frame:
Week 24
Reported as:
Number · participants
Stinging/Burning at Visit 7
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4748444546
Grade 1 - MInimal00010
Grade 2 - Moderate00000
Grade 3 - Severe00000
SecondaryScaling and Dryness at Baseline

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
Baseline
Reported as:
Number · participants
Scaling and Dryness at Baseline
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2524262916
Grade 1 - Minimal1619171521
Grade 2 - Mild65426
Grade 3 - Moderate00003
Grade 4 - Severe00000
SecondaryScaling and Dryness at Visit 2

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
24-48 hours after PDT #1
Reported as:
Number · participants
Scaling and Dryness at Visit 2
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None1920221718
Grade 1 - Minimal1316152322
Grade 2 - Mild108466
Grade 3 - Moderate54500
Grade 4 - Severe00100
SecondaryScaling and Dryness at Visit 3

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
Week 2
Reported as:
Number · participants
Scaling and Dryness at Visit 3
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2221202719
Grade 1 - Minimal1715161620
Grade 2 - Mild78836
Grade 3 - Moderate13300
Grade 4 - Severe01000
SecondaryScaling and Dryness at Visit 4

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
Week 4
Reported as:
Number · participants
Scaling and Dryness at Visit 4
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2424272818
Grade 1 - Minimal1918171422
Grade 2 - Mild36144
Grade 3 - Moderate10101
Grade 4 - Severe00000
SecondaryScaling and Dryness at Visit 5

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
Week 8
Reported as:
Number · participants
Scaling and Dryness at Visit 5
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None2330313117
Grade 1 - Minimal2116111318
Grade 2 - Mild32329
Grade 3 - Moderate00000
Grade 4 - Severe00000
SecondaryScaling and Dryness at Visit 6

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
Week 12
Reported as:
Number · participants
Scaling and Dryness at Visit 6
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None3234303323
Grade 1 - Minimal1312131117
Grade 2 - Mild22024
Grade 3 - Moderate00100
Grade 4 - Severe00000
SecondaryScaling and Dryness at Visit 7

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
Week 24
Reported as:
Number · participants
Scaling and Dryness at Visit 7
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None3126323728
Grade 1 - Minimal132211812
Grade 2 - Mild30115
Grade 3 - Moderate00001
Grade 4 - Severe00000
SecondaryOozing/Vesiculation/Crusting at Baseline

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
Baseline
Reported as:
Number · participants
Oozing/Vesiculation/Crusting at Baseline
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4547464344
Grade 1 - Minimal10131
Grade 2 - Mild11001
Grade 3 - Moderate00000
SecondaryOozing/Vesiculation/Crusting at Visit 2

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
24-48 hours after PDT #1
Reported as:
Number · participants
Oozing/Vesiculation/Crusting at Visit 2
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4339343443
Grade 1 - Minimal24592
Grade 2 - Mild24421
Grade 3 - Moderate01410
Grade 4 - Severe00000
SecondaryOozing/Vesiculation/Crusting at Visit 3

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
Week 2
Reported as:
Number · participants
Oozing/Vesiculation/Crusting at Visit 3
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4542454545
Grade 1 - Minimal15100
Grade 2 - Mild11110
Grade 3 - Moderate00000
SecondaryOozing/Vesiculation/Crusting at Visit 4

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
Week 4
Reported as:
Number · participants
Oozing/Vesiculation/Crusting at Visit 4
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4645464645
Grade 1 - Minimal13000
Grade 2 - Mild00000
Grade 3 - Moderate00000
SecondaryOozing/Vesiculation/Crusting at Visit 5

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
Week 8
Reported as:
Number · participants
Oozing/Vesiculation/Crusting at Visit 5
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4747454442
Grade 1 - Minimal01021
Grade 2 - Mild00000
Grade 3 - Moderate00001
SecondaryOozing/Vesiculation/Crusting at Visit 6

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
Week 12
Reported as:
Number · participants
Oozing/Vesiculation/Crusting at Visit 6
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4648444644
Grade 1 - Minimal10000
Grade 2 - Mild00000
Grade 3 - Moderate00000
SecondaryOozing/Vesiculation/Crusting at Visit 7

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
Week 24
Reported as:
Number · participants
Oozing/Vesiculation/Crusting at Visit 7
participantsBroad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle + BLUE Light Treatment
Grade 0 - None4748444546
Grade 1 - Minimal00010
Grade 2 - Mild00000
Grade 3 - Moderate00000

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Broad Area ALA 1-hour—5/48 (10.4%)0/48 (0%)
Broad Area ALA 2-hour—1/48 (2.1%)1/48 (2.1%)
Broad Area ALA 3-hour—3/47 (6.4%)1/47 (2.1%)
Spot ALA 2-hour—2/46 (4.3%)4/46 (8.7%)
Vehicle PDT—2/46 (4.3%)4/46 (8.7%)
Most frequent serious events
Showing 10 of 17
Most frequent serious events
EventBroad Area ALA 1-hourBroad Area ALA 2-hourBroad Area ALA 3-hourSpot ALA 2-hourVehicle PDT
strokeNervous system disorders0/480/480/471/460/46
prostate cancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)0/480/480/471/460/46
small bowel obstructionGastrointestinal disorders0/480/480/470/461/46
exacerbation of atrial fibrillationCardiac disorders0/480/480/470/461/46
splenectomySurgical and medical procedures0/480/480/470/461/46
pneumothoraxRespiratory, thoracic and mediastinal disorders0/481/481/470/460/46
lung cancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)0/480/481/470/460/46
gastrointestinal bleedGastrointestinal disorders0/480/481/470/460/46
renal cell carcinomaNeoplasms benign, malignant and unspecified (incl cysts and polyps)0/480/481/470/460/46
Kidney stoneRenal and urinary disorders1/480/480/470/460/46
Most frequent other events
Most frequent other events
EventBroad Area ALA 1-hourBroad Area ALA 2-hourBroad Area ALA 3-hourSpot ALA 2-hourVehicle PDT
squamous cell carcinoma of skinNeoplasms benign, malignant and unspecified (incl cysts and polyps)0/481/481/474/464/46

Baseline characteristics

Age, Continuous
Age, Continuous(years)Broad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle (VEH) + BLUE Light TreatmentTotal
Mean66.3 ± 7.067.1 ± 9.466.4 ± 10.669.5 ± 9.768.4 ± 9.467.5 ± 9.3
Sex: Female, Male
Sex: Female, Male(Participants)Broad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle (VEH) + BLUE Light TreatmentTotal
Female3572623
Male4543404440212
Region of Enrollment
Region of Enrollment(participants)Broad Area ALA 1-hour + BLUE Light TreatmentBroad Area ALA 2-hour + BLUE Light TreatmentBroad Area ALA 3-hour + BLUE Light TreatmentSpot ALA 2-hour + BLUE Light TreatmentVehicle (VEH) + BLUE Light TreatmentTotal
United States4848474646235
08

Study locations

13 sites
  • UCSD Dermatology Perlman Ambulatory Clinic
    La Jolla, California 92037, United States
  • Dermatology Research Associates
    Los Angeles, California 90045, United States
  • Therapeutics Clinical Research
    San Diego, California 92123, United States
  • Northwest Clinical Trials, Inc.
    Boise, Idaho 83704, United States
  • Altman Dermatology Associates
    Arlington Heights, Illinois 60005, United States
  • The Indiana Clinical Trials Center, PC
    Plainfield, Indiana 46168, United States
  • Minnesota Clinical Study Center
    Fridley, Minnesota 55432, United States
  • Dermatology Research Center of Cincinnati
    Cincinnati, Ohio 45220, United States
  • Oregon Medical Research Center, PC
    Portland, Oregon 97223, United States
  • Tennessee Clinical Research Center
    Nashville, Tennessee 37215, United States
  • DermResearch, Inc.
    Austin, Texas 78759, United States
  • Suzanne Bruce and Associates, P.A.,The Center for Skin Research
    Houston, Texas 77056, United States
  • Virginia Clinical Research Inc
    Norfolk, Virginia 23507, United States
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2011, a primary completion of Nov 2012 and a completion of Nov 2012. It does not say whether these dates are actual or estimated.

Results were first posted in Dec 2013, 1 year 1 month after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 15, 2011
First posted
Nov 22, 2011
Start
Dec 2011
Primary completionActual
Nov 2012
CompletionActual
Nov 2012
Results first posted
Dec 24, 2013
Last update
Oct 28, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 28, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01475955
Responsible party
Sponsor
First posted
Nov 22, 2011
Start date
Dec 2011
Primary completion
Nov 2012
Completion
Nov 2012
Results posted
Dec 24, 2013
Last update
Oct 28, 2016

Study contacts

Stuart Marcus, MD, PhD
study director · DUSA Pharmaceuticals, Inc.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Aminolevulinic Acid

Start the discussion